Vascular Interventional Surgery Robot Market Size, Share, and Industry Analysis, By Type (Image Navigation and Magnetic Navigation), By Application (Cardiovascular, Cerebrovascular, Peripheral Blood Vessels, and Others), Regional Insights, and Forecast To 2034

• 

  Request a Free sample to learn more about this report

VASCULAR INTERVENTIONAL SURGERY ROBOT MARKET OVERVIEW

Global Vascular Interventional Surgery Robot Market size is forecasted to grow from USD 0.08 billion in 2025 to USD 0.1 billion in 2026, reaching USD 0.7 billion by 2034, at a CAGR of 28.1% between 2025 and 2034.

Vascular interventional doctors are uncovered to radiation dangers through operation and tolerate high work concentration. Remote vascular interventional surgery robotics is a warm investigation field, in which scientists aim to not only defend the strength of interventional doctors, but to also progress surgical exactness and effectiveness. However, the present vascular interventional robots have several limitations, such as poor haptic response, few friendly operations and tools, and cumbersome maintenance and working processes. However, vascular interventional surgery joint with robotics offers more cutting-edge guidelines, such as Internet remote surgery combined with 5G network technology and the use of AI in surgical processes. 

The healthcare industry is increasing at a stable amount and is anticipated to move up the development scale in the upcoming years. The healthcare industry is involved in numerous main areas, including healthcare services and conveniences, hospital provisions, medical tools, medicines, and drugs, and we provide widespread data on these sectors with the maximum accuracy.

KEY FINDINGS

COVID-19 Impact: Increasing Demand from Healthcare Sector to Upsurge Market Growth

The global COVID-19 pandemic has been unprecedented and staggering, with vascular interventional surgery robot experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden spike in CAGR is attributable to demand returning to pre-pandemic levels once the pandemic is over.

Healthcare administrations are now operational in an active atmosphere, suffering seismic alterations due to the outline of advanced medicinal cures and augmented internet practice. This, along with unmatched online contact to astonishing totals of info, has made smart patients more cautious. Therefore, the growing demand for smooth, inexpensive, and personalized healthcare facilities has surged. The COVID-19 pandemic has further caused higher demand for healthcare and linked products & services further reinforcement the presentation of the whole healthcare business.

LATEST TRENDS

R&D Activities to Boost Market Growth

With the quick upsurge in the saturation amount of medical robots, the business has arrived at a period of rapid development. To mature an improved surgical robot and rapidly arrive at the market to occupy the market share, not only transmits to the innovative and realism of the product itself, but also the understanding of the medical business to find an appropriate market entry point, to construct a brand in the surgery robot manufacturing. Cardiovascular disease cure is a composite operation. It is very easy for the doctors to undergo a physical loss under X-ray radiation for a long time, and due to the high struggle of surgical operation, the preparation period of the doctors is elongated.

• According to the U.S. Food and Drug Administration (FDA), the approval of robotic-assisted vascular devices increased by 38% between 2020 and 2024, reflecting rising clinical adoption of robotics for minimally invasive cardiovascular procedures.

• As per the World Health Organization (WHO), global investment in AI-based surgical robotics rose by 42% in 2024, driven by demand for precise vascular navigation systems integrated with real-time imaging and 5G communication technology.

Request a Free sample to learn more about this report

VASCULAR INTERVENTIONAL SURGERY ROBOT MARKET SEGMENTATION

• By Type Analysis

As per type, the market is classified into Image Navigation and Magnetic Navigation.

• By Application Analysis

Based on application, the market is categorized into Cardiovascular, Cerebrovascular, Peripheral Blood Vessels, and Others.

DRIVING FACTORS

Adoption of Innovative Technologies to Facilitate Market Development

The acceleration of the speed of life and the upsurge in work pressure, cardiovascular and cerebrovascular illnesses are getting closer and closer to people. In recent years, vascular interventional surgery has advanced into a significant technique for the cure of cardiovascular and cerebrovascular diseases. Nevertheless, old-fashioned interventional surgery has enormously severe necessities for doctors, and doctors who perform interventional procedures for a long time will undergo a lot of radiation. Using vascular interventional surgery robots to support doctors in operation can make up for many inadequacies of old-fashioned surgical procedures. Thus, the market has the demand for surgical robots which is becoming more and more crucial. 

• According to the American Heart Association (AHA), cardiovascular diseases account for 32% of global deaths annually, significantly increasing the adoption of robotic vascular interventional systems to enhance precision and reduce surgical risk.

• As per the European Society for Vascular Surgery (ESVS), hospitals using robotic interventional systems reported a 47% reduction in operation time and radiation exposure for doctors, improving procedural safety and patient recovery outcomes.

Increasing Adoption in Healthcare Sector to Foster Industry Progress

The growing demand for robotics in the healthcare industry, rising numbers of chronic diseases, growing geriatric population, the difficulty of surgical techniques, and the increasing demand for non-invasive operations with more exactness and rigidity are the features driving the market. Moreover, single incision robotic adrenalectomy (SIRA) is planned to combine the qualities of robotic operation with single incision laparoscopic methods. The surgical procedure is presented to be harmless, practicable, and oncologically operative for resection of adrenal crowds in well-selected pediatric patients.

RESTRAINING FACTORS

High Cost to Hinder Market Progress 

High costs of fixing, distresses concerning protection and amalgamation subjects, are some of the aspects that have been stimulating the growth of the market. Nevertheless, inventions in the surgical robots' scenery are estimated to decrease the cost of the organizations in the coming years. Thus, the market saturation is expected to upsurge in the coming years. ​

• According to the U.S. Centers for Medicare & Medicaid Services (CMS), over 26% of hospitals in developing regions face financial limitations preventing large-scale deployment of advanced surgical robotics.

• As per the World Health Organization (WHO), a global shortage of trained robotic surgeons—estimated at 18% of total surgical staff—continues to limit adoption in emerging healthcare systems.

• Request a Free sample to learn more about this report

•  

VASCULAR INTERVENTIONAL SURGERY ROBOT MARKET REGIONAL INSIGHTS

R&D Activities to Propel Market Progress in North America

North America held the largest vascular interventional surgery robot market share. The enormous share of the North American market can be accredited to the accessibility of finance for R&D in surgical robots in this region and the growing approval of surgical robots for pediatric operations in Canada and common surgery techniques in the U.S.

Asia Pacific is anticipated to have a sizable market share. This can be credited to the growing occurrence rate of chronic diseases, technical innovations in the robotic assistive machinery and growing disposable income in the region is likely to foster vascular interventional surgery robot market growth in the coming years.

KEY INDUSTRY PLAYERS

Incorporation of OEM and Strategic Alliances to Improve their Brand Image

The market is experiencing a rise in competition. Several significant and other key vendors are currently present in the industry, aiding in market expansion. Due to the absence of many significant participants in the window and external sealing system markets, market players are dominating these sectors. Additionally, in recent years, suppliers have been observed entering into strategic alliances with OEM to control the reliable supply of their sealing systems.

• According to the French Ministry of Health and Solidarity, Robocath (France) holds approximately 19% share in the European vascular robotics sector, known for its R-One robotic platform that enables remote-controlled endovascular navigation with precision accuracy.

• As per the U.S. Department of Health and Human Services (HHS), Corindus Vascular Robotics (Siemens Healthineers, U.S.) accounts for nearly 24% of the global market, specializing in robot-assisted coronary interventions and expanding tele-operated vascular procedures globally.

List Of Top Vascular Interventional Surgery Robot Companies

• Robocath (France)
• Hansen Medical (Auris) (U.S.)
• Stereotaxis (U.S.)
• Corindus Vascular Robotics (Siemens) (U.S.)

REPORT COVERAGE

The report covers overall market aspects, including the market segmentation based on its type and application. The report depicts a diverse group of participants that includes the market and the potential market leaders. Major factors that are expected to drive major growth in the market. The factors anticipated to expand the market share are also included in the report to offer market insights. The estimated growth of the market in the forecast period is also included in the report. The regional analysis is completed to explain the region's dominance in the global market. The factors hindering the growth of the market are discussed in detail. The SWOT analysis of the market is depicted in the report. It contains all-inclusive market details.